Cargando…
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
5-Hydroxymethylcytosine (5hmC) is an important mammalian DNA epigenetic modification that has been linked to gene regulation and cancer pathogenesis. Here we explored the diagnostic potential of 5hmC in circulating cell-free DNA (cfDNA) using a sensitive chemical labeling-based low-input shotgun seq...
Autores principales: | Song, Chun-Xiao, Yin, Senlin, Ma, Li, Wheeler, Amanda, Chen, Yu, Zhang, Yan, Liu, Bin, Xiong, Junjie, Zhang, Weihan, Hu, Jiankun, Zhou, Zongguang, Dong, Biao, Tian, Zhiqi, Jeffrey, Stefanie S, Chua, Mei-Sze, So, Samuel, Li, Weimin, Wei, Yuquan, Diao, Jiajie, Xie, Dan, Quake, Stephen R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630676/ https://www.ncbi.nlm.nih.gov/pubmed/28820176 http://dx.doi.org/10.1038/cr.2017.106 |
Ejemplares similares
-
Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma
por: Zhao, Fu, et al.
Publicado: (2021) -
Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
por: Hu, Xinlei, et al.
Publicado: (2022) -
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
por: Guler, Gulfem D., et al.
Publicado: (2020) -
5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
por: Jhanwar, Shalu, et al.
Publicado: (2019) -
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
por: Li, Wenshuai, et al.
Publicado: (2017)